Portfolio
Overview

Watchlist
Overview


more

Portfolios Overview New Portfolio
Demo Portfolio
$75,350.00
Total Gain % 149.43%
Total Gain $25,350.00
Total Realised % 0.00%
Total Realised $0.00
Back
Watchlists Overview New Watchlist
Targets
33 Average Rating
Number of Companies 3
Date Created 04 Mar, 2015
Back
Portfolio Summary
Demo Portfolio
Market Value $75,350.00
Total Gain $25,350.00
(149.43%)
Value $42,315.00
Close Price (13 Apr) $141.05
Unrealised P/L (%) 149.40%
Unrealised P/L $25,350.00
Total $75,350.00
$25,350.00
Back
Back
Watchlist Summary
Targets
Short Name TGTS
Date Created 04 Mar, 2015
Current Price $64.95
Added Price $43.06
STRIDE Rating 36
Value Change (%) 50.85%
Current Price $33.88
Added Price $34.64
STRIDE Rating 25
Value Change (%) -2.19%
Current Price $26.74
Added Price $29.27
STRIDE Rating 35
Value Change (%) -8.63%
Total Buy0
Total Hold0
Total Sell3
Back
Back
Filter
Include in Feed
My Portfolios
My Watchlists
STRIDE Lists
Filter Feed By
STRIDE 3D VI
Activity
Upcoming
Warning
Back
Company FilterClear All
Filter by Company Descriptions
Filter by STRIDE Scores
Strength
to
Timing
to
Returns
to
Intrinsic Value
to
Dividends
to
Earnings Predictability
to
Rating
to
Back
Options
Add To Watchlist
Company Info (Sample)
Options
Add To Watchlist

3SBio Inc.

3SBio Inc.
Pharmaceuticals, Biotechnology and Life Sciences : Biotechnology.
1530 on The Stock Exchange of Hong Kong Ltd..
Price in Hong Kong Dollar, all financial data originally reported in Chinese Renminbi (Yuan).
Founded in 2006, the business is 11 years old.
The business last filed accounts on the 27 Sep, 2016.
Company website: www.3sbio.com
Show Company Details
STRIDE Rating
00
Buy
Hold
Sell
Hong Kong, Mid Cap
Market Capitalisation: HK元25,155.72M
Total Enterprise Value: Get a demo
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. Its products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. The company also offers IV Iron Sucrose, an iron sucrose injection product for iron deficiency anemia; SEPO, an injectable product for anemia associated with CKD, as well as CIA; and Sparin, an injectable low-molecular-weight heparin calcium product for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. In addition, it provides Intefen, a recombinant human interferon alpha-2a product for the treatment of malignancies of the lymphatic or hematopoietic system, and viral infectious diseases; and Inleusin, a recombinant human interleukin 2 product for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; and Gan Xin, a metadoxine drug for alcoholic liver disease. Further, the company offers Qiming Keli for Type 2 diabetic retinopathy; Yi Li Xi, a TZDS antidiabetic drug; Man di, an OTC drug for baldness; Lai Zi, a tacrolimus ointment for atopic dermatitis; Di Su, a BCG-PSN injection for chronic bronchitis, cold, and asthma; Lai Duo Fei for allergic rhinitis and antihistamines; Liranaftate, a glucosinolates carbamate antifungal drug for the treatment of tinea pedis, tinea corporis, and tinea cruris; and Amikacin to treat trauma infection caused by bacteria, as well as distributes anti-cancer drugs, such as Docetaxel, Anastrozole, and Azasetron. 3SBio Inc. sells its products to hospitals and medical institutions through in-house sales and marketing team, distributors, and third-party promoters. The company was incorporated in 2006 and is headquartered in Shenyang, the People’s Republic of China. Read More
Company Feed
Price & Valuation Info
Price Quote on 13th Apr '17
HK元9.79 0.09(0.93%)
52 Week Range
6.93
10.8
Interactive STRIDE chart with history.
Only available to subscribers.
Get a demo now.
Performance
1 month -0.07 (-0.71%)
year-to-date 2.24 (29.67%)
1 year -0.71 (-6.76%)
Show More Valuation Info
Momentum
vs 52week high 91%
vs 50d SMA 109%
vs 200d SMA120%
STRIDE Valuations
Consider Buy Get a demo
Fair Value Get a demo
Consider Sell Get a demo
Price/Adj. Earnings Get a demo
Price/Adj FCF Get a demo
Price/Adj. TBV Get a demo
Forecast Growth Get a demo
Other Valuations
Price/Book Get a demo
Price/Tangible Book Get a demo
Price/Sales Get a demo
Price/Earnings Get a demo
Price/Free Cashflow Get a demo
EV/EBITDA Get a demo
Dividend Yield Get a demo
Volume
Ave. Vol. last 6 months
Hide Extra Info
Scores
S
Strength
T
Timing
R
Returns
I
Intrinsic Value
D
Dividends
E
Earnings Predictability
Other Metrics
Altman Z-Score (Bankruptcy)
Greenblatt Rank (Magic Formula)
Piotroski F-Score (Financial Health)
Beneish M-Score (Earnings Manipulation)
Financials Get a demo
To The Top
Company Options
Add To Watchlist
Watchlists:
Targets
Options
Price Alert Email:
Price to alert at:*
When to alert:*
Cancel
Save
Price Alerts Configured:
Back

Portfolio
Overview

Watchlist
Overview

Feed
Filter


more